Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

ConferencePositive

AI Analysis

Summary

Palvella Therapeutics' Chief Scientific Officer Jeff Martini has been selected to present at an FDA public workshop on August 5th, 2026, focused on drug repurposing approaches and accelerating patient access to therapies for unmet medical needs.

Importance:2/10

Sentiment:

0.30

FDAdrug repurposingworkshoppublic meetingregulatory

Related Companies

$MDCE $DMAA

Read the original article

Published by GlobeNewswire Clinical Studies on July 30, 2026 11:30 AM

Read Original